Juan Miguel Mosquera
Researcher Next ID · RN-042166
Researcher · Biochemistry, Genetics and Molecular Biology
Ithaca, Israel
- Works count
- 480
- Citation count
- 23,755
- H-index
- 54
- i10-index
- 115
Research interests
Publications
Circulating tumor DNA profile recognizes transformation to castration-resistant neuroendocrine prostate cancer
Journal of Clinical Investigation · 2020 · https://doi.org/10.1172/jci131041
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer
Science Translational Medicine · 2019 · https://doi.org/10.1126/scitranslmed.aav0891
Genomic correlates of clinical outcome in advanced prostate cancer
Proceedings of the National Academy of Sciences · 2019 · https://doi.org/10.1073/pnas.1902651116
Clinical features of neuroendocrine prostate cancer
European Journal of Cancer · 2019 · https://doi.org/10.1016/j.ejca.2019.08.011
Upper tract urothelial carcinoma has a luminal-papillary T-cell depleted contexture and activated FGFR3 signaling
Nature Communications · 2019 · https://doi.org/10.1038/s41467-019-10873-y
A Phase II Trial of the Aurora Kinase A Inhibitor Alisertib for Patients with Castration-resistant and Neuroendocrine Prostate Cancer: Efficacy and Biomarkers
Clinical Cancer Research · 2018 · https://doi.org/10.1158/1078-0432.ccr-18-1912
Patient derived organoids to model rare prostate cancer phenotypes
Nature Communications · 2018 · https://doi.org/10.1038/s41467-018-04495-z
Personalized In Vitro and In Vivo Cancer Models to Guide Precision Medicine
Cancer Discovery · 2017 · https://doi.org/10.1158/2159-8290.cd-16-1154
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer
Nature Medicine · 2016 · https://doi.org/10.1038/nm.4045
Clonal evolution of chemotherapy-resistant urothelial carcinoma
Nature Genetics · 2016 · https://doi.org/10.1038/ng.3692
Integrative Clinical Genomics of Advanced Prostate Cancer
Cell · 2015 · https://doi.org/10.1016/j.cell.2015.05.001
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response
JAMA Oncology · 2015 · https://doi.org/10.1001/jamaoncol.2015.1313
The Placental Gene PEG10 Promotes Progression of Neuroendocrine Prostate Cancer
Cell Reports · 2015 · https://doi.org/10.1016/j.celrep.2015.07.012
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer
Nature Communications · 2014 · https://doi.org/10.1038/ncomms6383
Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer
Neoplasia · 2013 · https://doi.org/10.1593/neo.121550
Punctuated Evolution of Prostate Cancer Genomes
Cell · 2013 · https://doi.org/10.1016/j.cell.2013.03.021
Development and validation of a clinical cancer genomic profiling test based on massively parallel DNA sequencing
Nature Biotechnology · 2013 · https://doi.org/10.1038/nbt.2696
Challenges in Recognizing Treatment-Related Neuroendocrine Prostate Cancer
Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.41.5166
Targeted Next-generation Sequencing of Advanced Prostate Cancer Identifies Potential Therapeutic Targets and Disease Heterogeneity
European Urology · 2012 · https://doi.org/10.1016/j.eururo.2012.08.053
Current projects
No projects listed.